The Use of Bruton's Tyrosine Kinase Inhibitors to Treat Allergic Disorders.
Melanie C DispenzaPublished in: Current treatment options in allergy (2021)
These studies suggest that BTKis may be capable of preventing IgE-mediated anaphylaxis, paving the way for future trials in food allergy and urticaria.